Chemesis International Inc

Company Profile

Chemesis International Inc had its IPO on under the ticker symbol CADMF.

The company operates in the Healthcare sector and Drug Manufacturers-Specialty & Generic industry. Chemesis International Inc has a staff strength of 0 employees.

Stock update

Shares of Chemesis International Inc opened at $0.16 at the start of the last trading session i.e. 2023-09-12.

The stocks traded within a range of $0.16 - $0.16, and closed at $0.16.

This is a -5.88% slip from the previous day's closing price.

A total volume of 416 shares were traded at the close of the day’s session.

In the last one week, shares of Chemesis International Inc have slipped by -37.98%.

Chemesis International Inc's Key Ratios

Chemesis International Inc has a market cap of $4.22 million, indicating a price to book ratio of 23.274 and a price to sales ratio of 248.2123.

In the last 12-months Chemesis International Inc’s revenue was $22361 with a gross profit of $6570 and an EBITDA of $-1475781. The EBITDA ratio measures Chemesis International Inc's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, Chemesis International Inc’s operating margin was -7065.83% while its return on assets stood at -47.74% with a return of equity of -2687.31%.

In Q3, Chemesis International Inc’s quarterly earnings growth was a positive 0% while revenue growth was a negative 44.7%.

Chemesis International Inc’s PE and PEG Ratio

Forward PE

0

Trailing PE

0

PEG

Its diluted EPS in the last 12-months stands at $-0.26 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Chemesis International Inc’s profitability.

Chemesis International Inc stock is trading at a EV to sales ratio of 250.5165 and a EV to EBITDA ratio of -4.2333. Its price to sales ratio in the trailing 12-months stood at 248.2123.

Chemesis International Inc stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets

$1.41 million

Total Liabilities

$1.16 million

Operating Cash Flow

$-40000.00

Capital Expenditure

$40000

Dividend Payout Ratio

0%

Chemesis International Inc ended 2024 with $1.41 million in total assets and $0 in total liabilities. Its intangible assets were valued at $1.41 million while shareholder equity stood at $247684.00.

Chemesis International Inc ended 2024 with $0 in deferred long-term liabilities, $1.16 million in other current liabilities, 95476494.00 in common stock, $-102454042.00 in retained earnings and $0 in goodwill. Its cash balance stood at $931519.00 and cash and short-term investments were $0. The company’s total short-term debt was $0 while long-term debt stood at $0.

Chemesis International Inc’s total current assets stands at $1.29 million while long-term investments were $0 and short-term investments were $0. Its net receivables were $362425.00 compared to accounts payable of $1.03 million and inventory worth $0.

In 2024, Chemesis International Inc's operating cash flow was $-40000.00 while its capital expenditure stood at $40000.

Comparatively, Chemesis International Inc paid $0 in dividends in 2024.

Other key metrics

Current Trading Price

$0.16

52-Week High

$0.3

52-Week Low

$0.0101

Analyst Target Price

$

Chemesis International Inc stock is currently trading at $0.16 per share. It touched a 52-week high of $0.3 and a 52-week low of $0.3. Analysts tracking the stock have a 12-month average target price of $.

Its 50-day moving average was $0.16 and 200-day moving average was $0.1 The short ratio stood at 0 indicating a short percent outstanding of 0%.

Around 306.2% of the company’s stock are held by insiders while 0.3% are held by institutions.